Form 4 for ENTX Entera Bio Ltd.
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-27 · accession 0001178913-24-002887 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-29 | 2024-08-27 | ENTX | LIEBERMAN GERALD M | Dir | A - Grant | $0.00 | +27.3K | 254.2K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2024-08-27 | A | A | 27,261 | $0.00 | 254,222 | D | — | — |